China unveils system for postmarket medical-device monitoring

09/10/2008 | FDAnews

China's State Food and Drug Administration has issued a white paper detailing the government's system for tracking adverse events linked to medical devices. Under the system, 10 national centers are in charge of registration testing of imported products and domestic products with Class III classification.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC